Regarding the new coronavirus vaccine developed by the American pharmaceutical company Moderna, as a result of clinical trials in Japan, it was confirmed that the number of "neutralizing antibodies" that suppress the action of the virus increased in all who received two inoculations. I understand.
The Ministry of Health, Labor and Welfare is making final adjustments on the 20th of this month to determine whether or not to approve it.
Moderna signed a contract with the Japanese government to supply vaccines for 25 million people by September, and applied for approval to the Ministry of Health, Labor and Welfare in March.
Takeda Pharmaceutical Company Limited, which handles distribution in Japan, announced that it has conducted clinical trials on a total of 200 Japanese men and women over the age of 20 since January, and submitted the data to the government on the 10th.
According to this, it was confirmed that 28 days after the second inoculation, neutralizing antibodies that suppress the action of the virus increased in all those who completed the second inoculation.
On the other hand, no serious safety concerns were reported.
British pharmaceutical giant AstraZeneca has already submitted data from domestic clinical trials, and the Ministry of Health, Labor and Welfare will hold an expert group on the 20th of this month to decide whether or not to approve the vaccines of the two companies at the same time. Adjustments are in progress.